Phytochemical Name : Pheophorbide-a

Properties Information
PhytoCAT-ID PhytoCAT-1975
Phytochemical name or plant extracts Pheophorbide-a
PMID 20558270
Literature evidence Pheophorbide-a (Pa), one of the active components isolated from this herbal medicine has been proposed to be a potential natural photosensitizer for photodynamic therapy.
IUPAC name 3-(16-ethenyl-11-ethyl-4-hydroxy-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl)propanoic acid
Phytochemicals’ class or type of plant extracts Pheophorbide-a (Pa), one of the active components isolated from this herbal medicine has been proposed to be a potential natural photosensitizer for photodynamic therapy (Pa-PDT).
Source of phytochemicals or plant Extracts Scutellaria barbata
Geographical availability Assam, Bangladesh, China South-Central, China Southeast, East Himalaya, Japan, Korea, Laos, Myanmar, Nepal, Taiwan, Thailand, Vietnam, West Himalaya
Plant parts NA
Other cancers Breast cancer
Target gene or protein JNK, ERK
Gene or Protein evidence Activation of c-Jun N-terminal kinase (JNK) and inhibition of extracellular signal-regulated kinase (ERK) were occurred in the Pa-PDT-treated cells.
Target pathways Mitogen-activated protein kinase (MAPK) pathway was found to be triggered.
IC50 0.5 μM at 24h against MDA-MB-231
Potency Our findings suggested that Pa-PDT exhibited its anti-tumor effects by the activation of mitochondria-mediated apoptosis and the ERK-mediated autophagy in MDA-MB-231 cells.
Cell line/ mice model MDA-MB-231
Additional information  The present study suggested Pa-PDT is a potential protocol for the late phase human breast cancer, and it is the first study to demonstrate the Pa-PDT induced autophagy contributed to the anti-tumor effects of Pa-PDT on human cancer cells.
PubChem ID 167186
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:458159-1
Safety NA